See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Social Media
Natural Disasters
Artificial Intelligence
Donald Trump
Baseball
Tariffs
Stock Markets
Soccer
European Union
Real Estate
Education
Published • loading... • Updated

New Player Comes Into Lykos Sphere...Brit Hedge Fund Guy Sir Christopher Hohn... Psychedelic Alpha Calls Him, "ruthless activist investor."

Summary by Cannabis Law Report
Psychedelic Alpha reports In January, we reported on billionaire investor Antonio Gracias’ bid to take control of embattled MDMA drug developer Lykos Therapeutics. Now, Gracias appears to be teaming up with an unlikely co-investor. Psychedelic Alpha understands that the Musk associate and DOGE advisor is joined by an even deeper-pocketed individual: Sir Christopher Hohn. The British decabillonaire investment manager and […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
DoubleBlindDoubleBlind

Inside the Billionaire Takeover of Lykos—and Rick Doblin’s Comeback

As MDMA therapy hangs in the balance, a high-stakes power shift is underway. But will it bring real change or just new faces at the top? [...] Read More... The post Inside the Billionaire Takeover of Lykos—and Rick Doblin’s Comeback appeared first on DoubleBlind Mag.

Read Full Article
Cannabis Law ReportCannabis Law Report

New Player Comes Into Lykos Sphere...Brit Hedge Fund Guy Sir Christopher Hohn... Psychedelic Alpha Calls Him, "ruthless activist investor."

Psychedelic Alpha reports In January, we reported on billionaire investor Antonio Gracias’ bid to take control of embattled MDMA drug developer Lykos Therapeutics. Now, Gracias appears to be teaming up with an unlikely co-investor. Psychedelic Alpha understands that the Musk associate and DOGE advisor is joined by an even deeper-pocketed individual: Sir Christopher Hohn. The British decabillonaire investment manager and […]

Read Full Article
psychedelicalpha.compsychedelicalpha.com

Pα+ Psychedelic Bulletin #190: ‘Europe’s Most Feared Investor’ Teams Up with Musk Associate to Fund Lykos Therapeutics - Psychedelic Alpha

In January, we reported on billionaire investor Antonio Gracias’ bid to take control of embattled MDMA drug developer Lykos Therapeutics. Now, Gracias appears to be teaming up with an unlikely co-investor. Psychedelic Alpha understands that the Musk associate and DOGE advisor is joined by an even deeper-pocketed individual: Sir Christopher Hohn. Source

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

psychedelicalpha.com broke the news in on Thursday, March 6, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal